Donanemab Appropriate Use Recommendations

The AUR adapt the donanemab clinical trial criteria and protocol into clinical practice, in order to maximize the safe and efficacious translation of this novel therapy into patient care. The AUR are expected to evolve as more real-world data accumulate from ALZNET and other patient registries in the U.S. and globally.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_106086
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Donanemab Appropriate Use Recommendations

Gil D. Rabinovici
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Donanemab Appropriate Use Recommendations

Gil D. Rabinovici
article en

Abstract

The AUR adapt the donanemab clinical trial criteria and protocol into clinical practice, in order to maximize the safe and efficacious translation of this novel therapy into patient care. The AUR are expected to evolve as more real-world data accumulate from ALZNET and other patient registries in the U.S. and globally.

Alzheimer s & DementiaVol. 21(S5)
University Memory and Aging Center (US)
Partnerships for the goals
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Donanemab Appropriate Use Recommendations — Gil D. Rabinovici · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS